keyword
https://read.qxmd.com/read/36037303/a-phase-ii-randomized-trial-of-chemoradiation-with-or-without-metformin-in-locally-advanced-cervical-cancer
#21
JOURNAL ARTICLE
Kathy Han, Anthony Fyles, Tina Shek, Jennifer Croke, Neesha Dhani, David D'Souza, Ting-Yim Lee, Naz Chaudary, Jeff Bruce, Melania Pintilie, Rob Cairns, Douglass Vines, Sara Pakbaz, David Jaffray, Ur Metser, Marjan Rouzbahman, Michael Milosevic, Marianne Koritzinsky
PURPOSE: Tumor hypoxia is associated with poor response to radiation (RT). We previously discovered a novel mechanism of metformin: enhancing tumor RT response by decreasing tumor hypoxia. We hypothesized that metformin would decrease tumor hypoxia and improve cervical cancer response to RT. EXPERIMENTAL DESIGN: A window-of-opportunity, phase II randomized trial was performed in stage IB-IVA cervical cancer. Patients underwent screening positron emission tomography (PET) imaging with hypoxia tracer fluoroazomycin arabinoside (FAZA)...
August 29, 2022: Clinical Cancer Research
https://read.qxmd.com/read/36031465/extended-results-and-independent-validation-of-a-phase-2-trial-of-metastasis-directed-therapy-for-molecularly-defined-oligometastatic-prostate-cancer
#22
JOURNAL ARTICLE
Rachel M Glicksman, Matthew Ramotar, Ur Metser, Peter W Chung, Zhihui Liu, Douglass Vines, Antonio Finelli, Robert Hamilton, Neil E Fleshner, Nathan Perlis, Alexandre R Zlotta, Andrew Bayley, Joelle Helou, Srinivas Raman, Girish Kulkarni, Charles Catton, Tony Lam, Rosanna Chan, Padraig Warde, Mary Gospodarowicz, David A Jaffray, Alejandro Berlin
PURPOSE: The role of metastasis-directed therapy (MDT) in molecularly defined oligorecurrent prostate cancer (PCa) remains irresolute. We present extended follow-up and an independent validation cohort of a prospective trial. METHODS AND MATERIALS: This study consists of 2 sequential single-arm phase-2 trials of patients with biochemical recurrence (prostate specific antigen [PSA] 0.4-3.0 ng/mL) and negative conventional imaging after radical prostatectomy and postoperative radiation therapy...
August 25, 2022: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/35626003/chronic-lymphocytic-leukemia-progression-diagnosis-with-intrinsic-cellular-patterns-via-unsupervised-clustering
#23
JOURNAL ARTICLE
Pingjun Chen, Siba El Hussein, Fuyong Xing, Muhammad Aminu, Aparajith Kannapiran, John D Hazle, L Jeffrey Medeiros, Ignacio I Wistuba, David Jaffray, Joseph D Khoury, Jia Wu
Identifying the progression of chronic lymphocytic leukemia (CLL) to accelerated CLL (aCLL) or transformation to diffuse large B-cell lymphoma (Richter transformation; RT) has significant clinical implications as it prompts a major change in patient management. However, the differentiation between these disease phases may be challenging in routine practice. Unsupervised learning has gained increased attention because of its substantial potential in data intrinsic pattern discovery. Here, we demonstrate that cellular feature engineering, identifying cellular phenotypes via unsupervised clustering, provides the most robust analytic performance in analyzing digitized pathology slides (accuracy = 0...
May 13, 2022: Cancers
https://read.qxmd.com/read/35448725/noise-based-image-harmonization-significantly-increases-repeatability-and-reproducibility-of-radiomics-features-in-pet-images-a-phantom-study
#24
JOURNAL ARTICLE
Harald Keller, Tina Shek, Brandon Driscoll, Yiwen Xu, Brian Nghiem, Sadek Nehmeh, Milan Grkovski, Charles Ross Schmidtlein, Mikalai Budzevich, Yoganand Balagurunathan, John J Sunderland, Reinhard R Beichel, Carlos Uribe, Ting-Yim Lee, Fiona Li, David A Jaffray, Ivan Yeung
For multicenter clinical studies, characterizing the robustness of image-derived radiomics features is essential. Features calculated on PET images have been shown to be very sensitive to image noise. The purpose of this work was to investigate the efficacy of a relatively simple harmonization strategy on feature robustness and agreement. A purpose-built texture pattern phantom was scanned on 10 different PET scanners in 7 institutions with various different image acquisition and reconstruction protocols. An image harmonization technique based on equalizing a contrast-to-noise ratio was employed to generate a "harmonized" alongside a "standard" dataset for a reproducibility study...
April 13, 2022: Tomography: a Journal for Imaging Research
https://read.qxmd.com/read/35442519/digitally-enabled-hemovigilance-allows-real-time-response-to-transfusion-reactions
#25
JOURNAL ARTICLE
Colleen Villamin, Tonita Bates, Benjamin Mescher, Sandy Benitez, Fernando Martinez, Adriana Knopfelmacher, Mayrin Correa Medina, Kimberly Klein, Amitava Dasgupta, David A Jaffray, Carol Porter, Welela Tereffe, Luisa Gallardo, James Kelley
BACKGROUND: Transfusion carries a risk of transfusion reaction that is often underdiagnosed due to reliance on passive reporting. The study investigated the utility of digital methods to identify potential transfusion reactions, thus allowing real-time intervention for affected patients. METHOD: The hemovigilance unit monitored 3856 patients receiving 43,515 transfusions under the hemovigilance program. Retrospective comparison data included 298,498 transfusions...
May 2022: Transfusion
https://read.qxmd.com/read/35366339/a-roadmap-to-clinical-trials-for-flash
#26
REVIEW
Paige A Taylor, Jean M Moran, David A Jaffray, Jeffrey C Buchsbaum
While FLASH radiation therapy is inspiring enthusiasm to transform the field, it is neither new nor well understood with respect to the radiobiological mechanisms. As FLASH clinical trials are designed, it will be important to ensure we can deliver dose consistently and safely to every patient. Much like hyperthermia and proton therapy, FLASH is a promising new technology that will be complex to implement in the clinic and similarly will require customized credentialing for multi-institutional clinical trials...
June 2022: Medical Physics
https://read.qxmd.com/read/35314646/phantom-validation-of-a-conservation-of-activity-based-partial-volume-correction-method-for-arterial-input-function-in-dynamic-pet-imaging
#27
JOURNAL ARTICLE
Brandon Driscoll, Tina Shek, Douglass Vines, Alex Sun, David Jaffray, Ivan Yeung
Dynamic PET (dPET) imaging can be utilized to perform kinetic modelling of various physiologic processes, which are exploited by the constantly expanding range of targeted radiopharmaceuticals. To date, dPET remains primarily in the research realm due to a number of technical challenges, not least of which is addressing partial volume effects (PVE) in the input function. We propose a series of equations for the correction of PVE in the input function and present the results of a validation study, based on a purpose built phantom...
March 21, 2022: Tomography: a Journal for Imaging Research
https://read.qxmd.com/read/35090025/predictive-radiation-oncology-a-new-nci-doe-scientific-space-and-community
#28
JOURNAL ARTICLE
Jeffrey C Buchsbaum, David A Jaffray, Demba Ba, Lynn L Borkon, Christine Chalk, Caroline Chung, Matthew A Coleman, C Norman Coleman, Maximilian Diehn, Kelvin K Droegemeier, Heiko Enderling, Michael G Espey, Emily J Greenspan, Christopher M Hartshorn, Thuc Hoang, H Timothy Hsiao, Cynthia Keppel, Nathan W Moore, Fred Prior, Eric A Stahlberg, Georgia Tourassi, Karen E Willcox
With a widely attended virtual kickoff event on January 29, 2021, the National Cancer Institute (NCI) and the Department of Energy (DOE) launched a series of 4 interactive, interdisciplinary workshops-and a final concluding "World Café" on March 29, 2021-focused on advancing computational approaches for predictive oncology in the clinical and research domains of radiation oncology. These events reflect 3,870 human hours of virtual engagement with representation from 8 DOE national laboratories and the Frederick National Laboratory for Cancer Research (FNL), 4 research institutes, 5 cancer centers, 17 medical schools and teaching hospitals, 5 companies, 5 federal agencies, 3 research centers, and 27 universities...
January 28, 2022: Radiation Research
https://read.qxmd.com/read/35020640/lesion-based-radiomics-signature-in-pretherapy-18f-fdg-pet-predicts-treatment-response-to-ibrutinib-in-lymphoma
#29
JOURNAL ARTICLE
Jorge E Jimenez, Dong Dai, Guofan Xu, Ruiyang Zhao, Tengfei Li, Tinsu Pan, Linghua Wang, Yingyan Lin, Zhangyang Wang, David Jaffray, John D Hazle, Homer A Macapinlac, Jia Wu, Yang Lu
PURPOSE: The aim of this study was to develop a pretherapy PET/CT-based prediction model for treatment response to ibrutinib in lymphoma patients. PATIENTS AND METHODS: One hundred sixty-nine lymphoma patients with 2441 lesions were studied retrospectively. All eligible lymphomas on pretherapy 18F-FDG PET images were contoured and segmented for radiomic analysis. Lesion- and patient-based responsiveness to ibrutinib was determined retrospectively using the Lugano classification...
January 11, 2022: Clinical Nuclear Medicine
https://read.qxmd.com/read/34894495/impact-of-pet-scanner-non-linearity-on-the-estimation-of-hypoxic-fraction-in-cervical-cancer-patients
#30
JOURNAL ARTICLE
Jennifer Gottwald, Kathy Han, Michael Milosevic, Ivan Yeung, David A Jaffray
BACKGROUND: Tumor hypoxia is defined as a low oxygen level in tissue and is associated with poor clinical outcome after chemo-/radiotherapy and surgery in many solid tumor types. Positron Emission Tomography (PET) imaging provides a non-invasive means of measuring local variations in the uptake of hypoxia-targeted agents (e.g. FAZA or FMISO). Accurate quantification of uptake is critically dependent on the PET scanner's linear count rate performance. In the context of cervix cancer, high PET agent accumulation in the bladder, low uptake in the tumor, and their relative proximity makes an accurate quantification of the tumor's hypoxic fraction challenging...
December 8, 2021: Physica Medica: PM
https://read.qxmd.com/read/34853038/cancer-needs-a-robust-metadata-supply-chain-to-realize-the-promise-of-artificial-intelligence
#31
JOURNAL ARTICLE
Caroline Chung, David A Jaffray
Profound advances in computational methods, including artificial intelligence (AI), present the opportunity to use the exponentially growing volume and complexity of available cancer measurements toward data-driven personalized care. While exciting, this opportunity has highlighted the disconnect between the promise of compute and the supply of high-quality data. The current paradigm of ad-hoc aggregation and curation of data needs to be replaced with a "metadata supply chain" that provides robust data in context with known provenance, that is, lineage and comprehensive data governance that will allow the promise of AI technology to be realized to its full potential in clinical practice...
December 1, 2021: Cancer Research
https://read.qxmd.com/read/34841195/radiological-tumor-classification-across-imaging-modality-and-histology
#32
JOURNAL ARTICLE
Jia Wu, Chao Li, Michael Gensheimer, Sukhmani Padda, Fumi Kato, Hiroki Shirato, Yiran Wei, Carola-Bibiane Schönlieb, Stephen John Price, David Jaffray, John Heymach, Joel W Neal, Billy W Loo, Heather Wakelee, Maximilian Diehn, Ruijiang Li
Radiomics refers to the high-throughput extraction of quantitative features from radiological scans and is widely used to search for imaging biomarkers for prediction of clinical outcomes. Current radiomic signatures suffer from limited reproducibility and generalizability, because most features are dependent on imaging modality and tumor histology, making them sensitive to variations in scan protocol. Here, we propose novel radiological features that are specially designed to ensure compatibility across diverse tissues and imaging contrast...
September 2021: Nature Machine Intelligence
https://read.qxmd.com/read/34722795/flat-panel-conebeam-ct-in-the-clinic-history-and-current-state
#33
JOURNAL ARTICLE
Rebecca Fahrig, David A Jaffray, Ioannis Sechopoulos, J Webster Stayman
Research into conebeam CT concepts began as soon as the first clinical single-slice CT scanner was conceived. Early implementations of conebeam CT in the 1980s focused on high-contrast applications where concurrent high resolution ( <mml:math xmlns:mml="https://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mo><</mml:mo> <mml:mn>200</mml:mn> <mml:mtext>  </mml:mtext> <mml:mi>μ</mml:mi> <mml:mi>m</mml:mi></mml:mrow> </mml:math> ), for visualization of small contrast-filled vessels, bones, or teeth, was an imaging requirement that could not be met by the contemporaneous CT scanners...
September 2021: Journal of Medical Imaging
https://read.qxmd.com/read/34650009/incorporating-cross-voxel-exchange-into-the-analysis-of-dynamic-contrast-enhanced-imaging-data-theory-simulations-and-experimental-results
#34
JOURNAL ARTICLE
Noha Sinno, Edward Taylor, Michael Milosevic, David A Jaffray, Catherine Coolens
Predictions of tumour perfusion are key determinants of drug delivery and responsiveness to therapy. Pharmacokinetic models allow for the estimation of perfusion properties of tumour tissues but many assume no dispersion associated with tracer transport away from the capillaries and through the tissue. At the level of a voxel, this translates to assuming no cross-voxel tracer exchange, often leading to the misinterpretation of derived perfusion parameters. Tofts model (TM), a compartmental model widely used in oncology, also makes this assumption...
October 14, 2021: Physics in Medicine and Biology
https://read.qxmd.com/read/34505705/artificial-intelligence-strategy-integrating-morphologic-and-architectural-biomarkers-provides-robust-diagnostic-accuracy-for-disease-progression-in-chronic-lymphocytic-leukemia
#35
JOURNAL ARTICLE
Siba El Hussein, Pingjun Chen, L Jeffrey Medeiros, Ignacio I Wistuba, David Jaffray, Jia Wu, Joseph D Khoury
Artificial intelligence-based tools designed to assist in the diagnosis of lymphoid neoplasms remain limited. The development of such tools can add value as a diagnostic aid in the evaluation of tissue samples involved by lymphoma. A common diagnostic question is the determination of chronic lymphocytic leukemia (CLL) progression to accelerated CLL (aCLL) or transformation to diffuse large B-cell lymphoma (Richter transformation; RT) in patients who develop progressive disease. The morphologic assessment of CLL, aCLL, and RT can be diagnostically challenging...
January 2022: Journal of Pathology
https://read.qxmd.com/read/34306954/evaluating-an-image-guided-operating-room-with-cone-beam-ct-for-skull-base-surgery
#36
JOURNAL ARTICLE
Nidal Muhanna, Catriona M Douglas, Michael J Daly, Harley H L Chan, Robert Weersink, Jason Townson, Eric Monteiro, Eugene Yu, Emilie Weimer, Walter Kucharczyk, David A Jaffray, Jonathan C Irish, John R de Almeida
Importance  Skull base surgery requires precise preoperative assessment and intraoperative management of the patient. Surgical navigation is routinely used for complex skull base cases; however, the image guidance is commonly based on preoperative scans alone. Objective  The primary objective of this study was to assess the image quality of intraoperative cone-beam computed tomography (CBCT) within anatomical landmarks used in sinus and skull base surgery. The secondary objective was to assess the registration error of a surgical navigation system based on intraoperative CBCT...
July 2021: Journal of Neurological Surgery. Part B, Skull Base
https://read.qxmd.com/read/34123126/-in-situ-tissue-pathology-from-spatially-encoded-mass-spectrometry-classifiers-visualized-in-real-time-through-augmented-reality
#37
JOURNAL ARTICLE
Michael Woolman, Jimmy Qiu, Claudia M Kuzan-Fischer, Isabelle Ferry, Delaram Dara, Lauren Katz, Fowad Daud, Megan Wu, Manuela Ventura, Nicholas Bernards, Harley Chan, Inga Fricke, Mark Zaidi, Brad G Wouters, James T Rutka, Sunit Das, Jonathan Irish, Robert Weersink, Howard J Ginsberg, David A Jaffray, Arash Zarrine-Afsar
Integration between a hand-held mass spectrometry desorption probe based on picosecond infrared laser technology (PIRL-MS) and an optical surgical tracking system demonstrates in situ tissue pathology from point-sampled mass spectrometry data. Spatially encoded pathology classifications are displayed at the site of laser sampling as color-coded pixels in an augmented reality video feed of the surgical field of view. This is enabled by two-way communication between surgical navigation and mass spectrometry data analysis platforms through a custom-built interface...
July 23, 2020: Chemical Science
https://read.qxmd.com/read/33685838/curative-intent-metastasis-directed-therapies-for-molecularly-defined-oligorecurrent-prostate-cancer-a-prospective-phase-ii-trial-testing-the-oligometastasis-hypothesis
#38
JOURNAL ARTICLE
Rachel M Glicksman, Ur Metser, Douglass Vines, John Valliant, Zhihui Liu, Peter W Chung, Robert G Bristow, Antonio Finelli, Robert Hamilton, Neil E Fleshner, Nathan Perlis, Alexandre R Zlotta, David Green, Andrew Bayley, Joelle Helou, Srinivas Raman, Girish Kulkarni, Charles Catton, Tony Lam, Rosanna Chan, Padraig Warde, Mary Gospodarowicz, David A Jaffray, Alejandro Berlin
BACKGROUND: The hypothesis of a curable oligometastatic prostate cancer (PCa) state remains to be clinically-proven. Conventional imaging often fails to localize early recurrences, hampering the potential for radical approaches. OBJECTIVE: We hypothesize that prostate-specific membrane antigen (PSMA)-targeted PET-MR/CT allows for earlier detection and localization of oligorecurrent-PCa, unveiling a molecularly-defined state amenable to curative-intent metastasis-directed treatment (MDT)...
September 2021: European Urology
https://read.qxmd.com/read/33413895/in-the-era-of-deep-learning-why-reconstruct-an-image-at-all
#39
JOURNAL ARTICLE
Caroline Chung, Jayashree Kalpathy-Cramer, Michael V Knopp, David A Jaffray
No abstract text is available yet for this article.
January 2021: Journal of the American College of Radiology: JACR
https://read.qxmd.com/read/33220507/assessment-of-a-liposomal-ct-optical-contrast-agent-for-image-guided-head-and-neck-surgery
#40
JOURNAL ARTICLE
Nidal Muhanna, Donovan Eu, Harley Hl Chan, Michael Daly, Inga B Fricke, Catriona M Douglas, Jason L Townson, Jinzi Zheng, Christine Allen, David A Jaffray, Jonathan C Irish
BACKGROUND: This study evaluates a long-acting liposomal fluorescence / CT dual-modality contrast agent (CF800) in head and neck cancer to enhance intraoperative tumor demarcation with fluorescence imaging and cone-beam computed tomography (CBCT). METHODS: CF800 was administered to 12 buccal cancer-bearing rabbits. Imaging was acquired at regular timepoints to quantify time-dependent contrast enhancement. Surgery was performed 5-7days after, with intraoperative near-infrared fluorescence endoscopy and CBCT, followed by histological and ex-vivo fluorescence assessment...
November 18, 2020: Nanomedicine: Nanotechnology, Biology, and Medicine
keyword
keyword
80641
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.